Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025

Core Insights - Guardant Health, Inc. is set to present data on the importance of blood-based testing in enhancing cancer screening adherence at the ACG 2025 Annual Meeting [1] Company Overview - Guardant Health is recognized as a leading precision oncology company [1] Event Details - The presentation will take place during the American College of Gastroenterology (ACG) 2025 Annual Meeting in Phoenix, Arizona, from October 24 to October 29, 2025 [1]